First-in-human Integrated Endoscopic Ultrasound (EUS) Navigation System Clinical Study
NCT ID: NCT06798545
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
64 participants
INTERVENTIONAL
2025-01-28
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The "EZ-EUS" system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure.
In this study, the intended purpose of the "EZ-EUS" system is to help echo-endoscopy operators to easily identify and assess the pancreatic gland, and to facilitate the detection of any lesions.
The hypothesis is that, thanks to this tool, procedure times will be shortened, and the pancreas and its lesions will be fully imaged to facilitate their localization and characterization.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study
NCT05515705
EUS for Gastrointestinal Disorders: a Registry
NCT02855151
Artificial Intelligence vs Endoscopist Identification in EUS Normal Anatomy
NCT06279546
EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract
NCT02744651
Endosonography For Right Side Acute Intestinal Mal-Symptoms (EFRAIM- Study)
NCT01080690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The American Society for Gastrointestinal Endoscopy (ASGE) has recommended the performance of a minimum of 190 supervised EUS for practicing autonomous EUS. However, the compliance of these parameters does not guarantee competence achievement, and there is a wide variability between endoscopists leading to disparities in the techniques' quality and irregular outcomes.
The "EZ-EUS" system is designed to help the operator understand the orientation and the position of the probe tip in the patient. This system offers navigation similar to that of the Global Positioning System (GPS), but for EUS procedures. To achieve this, it uses a 3D model based on scanner imaging data recorded before the procedure.
In this study, the intended purpose of the "EZ-EUS" system is to assist echo-endoscopy operators in accurately locating the pancreatic gland, conducting a comprehensive evaluation of the region of interest, and facilitating the detection and identification of lesions within it. We hypothesize that this tool will streamline procedure times and enable comprehensive imaging of the pancreas and its lesions, thereby reducing the need for expert guidance for trainees and shortening the EUS learning curve. This study is exploratory, prospective, monocentric and will compare two randomized groups (with and without the EZ-EUS navigation system).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EUS with EZ-EUS navigation system
EUS with the experimental navigation system
endoscopic ultrasound with navigation system
Use of the EZ-EUS navigation system during the procedure
Standard EUS
EUS in standard condition
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endoscopic ultrasound with navigation system
Use of the EZ-EUS navigation system during the procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient having a EUS procedure for pancreas study planned within the frame of his or her clinical care.
* Patient whom pre-operative imaging indicates one lesion, a suspicion of lesion, chronic pancreatitis or fatty pancreas.
* Patient with a good definition on the CT scan done within the year to the EUS.
* Patient able to receive and understand information related to the study and give his or her written consent.
* Patient affiliated to the French social security system.
Exclusion Criteria
* Patient with known abnormal anatomy of the upper digestive tract.
* Patient wearing a pacemaker.
* Patients with comorbidities that may increase the risk of perforation.
* Patient presenting, according to the investigator's judgment, a disease which may prevent participation in the procedures provided for by the study.
* Patient with an ASA \>3. Patient with ASA=3 must be validated by the Principal
* Investigator (PI).
* Patient unable to tolerate general anesthesia.
* Patient with a body mass index (BMI) \< 18,5 and \> 40.
* Patient with weight variations \>10% between the date on which the CT scan was performed and the date of the procedure.
* Pregnant or lactating patient.
* Patient in exclusion period (determined by a previous or a current study).
* Patient under guardianship or trusteeship.
* Patient under the protection of justice of deprives of liberty.
* Patient in situation of emergency
• Patient in need of the balloon during the navigation will be excluded of the study (Experimental group)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCAD
UNKNOWN
IHU Strasbourg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonardo SOSA-VALENCIA, MD
Role: PRINCIPAL_INVESTIGATOR
IHU Strasbourg, HUS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.